ConductScience.org, home

Paper3672575

Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization.

Crist KD and 2 others. Ther Drug Monit, 1987. Cited by 49 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Papers, record 3672575. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3672575

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization.
PubMed
Journal
Ther Drug Monit
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
2.34
iCite
Revised in PubMed
2019-09-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crist KDK D
2Nahata MCM C
3Ety JJ

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Monitoring, PhysiologicMajor topic
Adult
Aged
Aminoglycosides
Costs and Cost Analysis
Humans
Kidney
Length of Stay
Middle Aged
United States

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
39928653Characterizing pre-discharge interventions to reduce length of stay for older adults: A scoping review.PLoS One2025https://conductscience.org/library/papers/39928653PubMed
39011355Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit.J Pharm Policy Pract2024https://conductscience.org/library/papers/39011355PubMed
28178770Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev2017https://conductscience.org/library/papers/28178770PubMed
27412506High throughput LSPR and SERS analysis of aminoglycoside antibiotics.Analyst2016https://conductscience.org/library/papers/27412506PubMed
27330257Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients.J Basic Clin Pharm2016https://conductscience.org/library/papers/27330257PubMed
25610196Therapeutic drug monitoring of gentamicin in patients with bronchopneumonia: cost considerations and patient outcomes.Eurasian J Med2012https://conductscience.org/library/papers/25610196PubMed
25083229Outcomes in patients with gram-negative sepsis treated with gentamicin.Ther Adv Drug Saf2012https://conductscience.org/library/papers/25083229PubMed
17293388Vancomycin administration: the impact of multidisciplinary interventions.J Clin Pathol2007https://conductscience.org/library/papers/17293388PubMed
11735602Pharmacogenetics: the therapeutic drug monitoring of the future?Clin Pharmacokinet2001https://conductscience.org/library/papers/11735602PubMed
11475466Therapeutic drug monitoring: do the improved outcomes justify the costs?Clin Pharmacokinet2001https://conductscience.org/library/papers/11475466PubMed
10147022Pharmacoeconomics of antibacterial treatment.Pharmacoeconomics1992https://conductscience.org/library/papers/10147022PubMed
10146946Methods of minimising the cost of aminoglycoside therapy to hospitals.Pharmacoeconomics1993https://conductscience.org/library/papers/10146946PubMed
10146877Economic aspects of pharmacokinetic services.Pharmacoeconomics1993https://conductscience.org/library/papers/10146877PubMed
10073735The therapeutic monitoring of antimicrobial agents.Br J Clin Pharmacol1999https://conductscience.org/library/papers/10073735PubMed
9655989A gentamicin order form improves its use.West J Med1998https://conductscience.org/library/papers/9655989PubMed
9571300Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?Clin Pharmacokinet1998https://conductscience.org/library/papers/9571300PubMed
9297729Pharmacoeconomics and therapeutic drug monitoring.Pharm World Sci1997https://conductscience.org/library/papers/9297729PubMed
8527010How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions?Drug Saf1995https://conductscience.org/library/papers/8527010PubMed
8137600Cost considerations in therapeutic drug monitoring of aminoglycosides.Clin Pharmacokinet1994https://conductscience.org/library/papers/8137600PubMed
7988099Therapeutic drug monitoring and patient outcome. A review of the issues.Clin Pharmacokinet1994https://conductscience.org/library/papers/7988099PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3672575

GET https://conductscience.org/api/papers/v1/3672575/cited_by?page=2